Medix CBD

Medix CBD is a United States-based manufacturing startup, founded in 2017, with a slogan "Protecting the industry with dedicated quality and preservation." The company is dedicated to producing high-quality CBD products, sourced from local hemp in Kentucky and manufactured in modern, clean facilities. Their commitment to quality is evident as every ingredient is lab-tested. Their last investment was a Seed Round investment in 10 April 2019, coming from CBD Capital Group. Medix CBD's mission goes beyond just producing CBD products; it aims to change the way people perceive natural medicine. They emphasize the benefits of CBD, such as pain relief without side effects, in comparison to traditional prescription drugs. The startup coalesces the experience gained from working with other brands, and pledges to deliver even better products to the market, catering from small individual orders to large-scale store demands. Their vision is to elevate the standards in the CBD industry, promising reliability and an unwavering dedication to quality. In conclusion, Medix CBD, with its solid foundation in the industry and support from CBD Capital Group, is well-positioned to lead the market with its high-quality, lab-tested, and locally sourced CBD products. The startup's dedication to changing the perception of natural medicine presents a substantial opportunity for investors looking to support innovation in the increasingly popular CBD industry.